DSE: JMISMDL Statistics
Total Valuation
JMI Syringes & Medical Devices has a market cap or net worth of BDT 3.87 billion. The enterprise value is 3.85 billion.
Market Cap | 3.87B |
Enterprise Value | 3.85B |
Important Dates
The next estimated earnings date is Wednesday, January 29, 2025.
Earnings Date | Jan 29, 2025 |
Ex-Dividend Date | Nov 19, 2024 |
Share Statistics
JMI Syringes & Medical Devices has 30.06 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 30.06M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 66.24.
PE Ratio | 66.24 |
Forward PE | n/a |
PS Ratio | 2.12 |
PB Ratio | 1.47 |
P/TBV Ratio | 1.47 |
P/FCF Ratio | 36.82 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.37, with an EV/FCF ratio of 36.61.
EV / Earnings | 65.88 |
EV / Sales | 2.11 |
EV / EBITDA | 16.37 |
EV / EBIT | 23.16 |
EV / FCF | 36.61 |
Financial Position
The company has a current ratio of 7.83, with a Debt / Equity ratio of 0.01.
Current Ratio | 7.83 |
Quick Ratio | 3.31 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.08 |
Debt / FCF | 0.17 |
Interest Coverage | 129.12 |
Financial Efficiency
Return on equity (ROE) is 2.24% and return on invested capital (ROIC) is 3.91%.
Return on Equity (ROE) | 2.24% |
Return on Assets (ROA) | 3.50% |
Return on Capital (ROIC) | 3.91% |
Revenue Per Employee | 1.87M |
Profits Per Employee | 59,712 |
Employee Count | 978 |
Asset Turnover | 0.61 |
Inventory Turnover | 2.06 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.63% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -49.63% |
50-Day Moving Average | 129.74 |
200-Day Moving Average | 146.55 |
Relative Strength Index (RSI) | 42.39 |
Average Volume (20 Days) | 10,653 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JMI Syringes & Medical Devices had revenue of BDT 1.82 billion and earned 58.40 million in profits. Earnings per share was 1.94.
Revenue | 1.82B |
Gross Profit | 326.16M |
Operating Income | 166.14M |
Pretax Income | 162.21M |
Net Income | 58.40M |
EBITDA | 233.17M |
EBIT | 166.14M |
Earnings Per Share (EPS) | 1.94 |
Balance Sheet
The company has 38.93 million in cash and 17.73 million in debt, giving a net cash position of 21.20 million or 0.71 per share.
Cash & Cash Equivalents | 38.93M |
Total Debt | 17.73M |
Net Cash | 21.20M |
Net Cash Per Share | 0.71 |
Equity (Book Value) | 2.63B |
Book Value Per Share | 87.39 |
Working Capital | 1.36B |
Cash Flow
In the last 12 months, operating cash flow was 117.04 million and capital expenditures -11.97 million, giving a free cash flow of 105.07 million.
Operating Cash Flow | 117.04M |
Capital Expenditures | -11.97M |
Free Cash Flow | 105.07M |
FCF Per Share | 3.50 |
Margins
Gross margin is 17.88%, with operating and profit margins of 9.11% and 3.20%.
Gross Margin | 17.88% |
Operating Margin | 9.11% |
Pretax Margin | 8.89% |
Profit Margin | 3.20% |
EBITDA Margin | 12.78% |
EBIT Margin | 9.11% |
FCF Margin | 5.76% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.78%.
Dividend Per Share | 1.00 |
Dividend Yield | 0.78% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 50.92% |
Buyback Yield | n/a |
Shareholder Yield | 0.78% |
Earnings Yield | 1.51% |
FCF Yield | 2.72% |
Stock Splits
The last stock split was on November 15, 2022. It was a forward split with a ratio of 1.36.
Last Split Date | Nov 15, 2022 |
Split Type | Forward |
Split Ratio | 1.36 |
Scores
JMI Syringes & Medical Devices has an Altman Z-Score of 12.15.
Altman Z-Score | 12.15 |
Piotroski F-Score | n/a |